AB
Amalgamated Bank Portfolio holdings
AUM
$13B
1-Year Return
23.92%
This Quarter Return
+9.8%
1 Year Return
+23.92%
3 Year Return
+105.94%
5 Year Return
+196.1%
10 Year Return
+496.3%
AUM
$12.4B
AUM Growth
+$625M
(+5.3%)
Cap. Flow
-$270M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
24.82%
Holding
3,231
New
284
Increased
841
Reduced
1,795
Closed
192
Top Buys
| 1 |
Palo Alto Networks
PANW
|
+$11.8M |
| 2 |
Merck
MRK
|
+$5.75M |
| 3 |
Crown Holdings
CCK
|
+$4.59M |
| 4 |
Ovintiv
OVV
|
+$4.51M |
| 5 |
GTM
ZoomInfo Technologies
GTM
|
+$4.1M |
Top Sells
| 1 |
Apple
AAPL
|
+$26.8M |
| 2 |
Microsoft
MSFT
|
+$19.3M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$18.2M |
| 4 |
Chevron
CVX
|
+$14.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$13.5M |
Sector Composition
| 1 | Technology | 26.98% |
| 2 | Healthcare | 13.15% |
| 3 | Financials | 12.02% |
| 4 | Consumer Discretionary | 11.67% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Ecovyst
ECVT
$1.06B
| $112K | ﹤0.01% |
9,732
+1,272
| +15% | +$14.6K |
|
2027
RxSight
RXST
$381M
| $111K | ﹤0.01% |
3,850
+734
| +24% | +$21.2K |
|
2028
Lifestance Health
LFST
$2.03B
| $110K | ﹤0.01% |
12,072
+4,307
| +55% | +$39.2K |
|
2029
Aclaris Therapeutics
ACRS
$211M
| $109K | ﹤0.01% |
10,484
+1,386
| +15% | +$14.4K |
|
2030
CryoPort
CYRX
$433M
| $109K | ﹤0.01% |
6,294
+406
| +7% | +$7.03K |
|
2031
Eventbrite
EB
$262M
| $109K | ﹤0.01% |
11,374
+900
| +9% | +$8.63K |
|
|
ETWO
2032
DELISTED
E2open Parent Holdings
ETWO
| $109K | ﹤0.01% |
19,526
-1,534
| -7% | -$8.56K |
|
2033
Globalstar
GSAT
$3.79B
| $109K | ﹤0.01% |
6,724
+604
| +10% | +$9.79K |
|
2034
Amplitude
AMPL
$1.47B
| $108K | ﹤0.01% |
9,825
+2,021
| +26% | +$22.2K |
|
2035
CRA International
CRAI
$1.3B
| $108K | ﹤0.01% |
1,057
+78
| +8% | +$7.97K |
|
2036
Gulfport Energy Corp
GPOR
$3.06B
| $108K | ﹤0.01% |
1,025
-547
| -35% | -$57.6K |
|
2037
Ivanhoe Electric
IE
$1.14B
| $107K | ﹤0.01% |
8,214
+2,501
| +44% | +$32.6K |
|
2038
Relay Therapeutics
RLAY
$688M
| $107K | ﹤0.01% |
8,557
-651
| -7% | -$8.14K |
|
|
ATSG
2039
DELISTED
Air Transport Services Group, Inc.
ATSG
| $107K | ﹤0.01% |
5,668
-1,148
| -17% | -$21.7K |
|
|
NVRO
2040
DELISTED
NEVRO CORP.
NVRO
| $107K | ﹤0.01% |
4,210
-737
| -15% | -$18.7K |
|
2041
Phibro Animal Health
PAHC
$1.61B
| $106K | ﹤0.01% |
7,772
-1,428
| -16% | -$19.5K |
|
2042
The Beauty Health Co
SKIN
$321M
| $106K | ﹤0.01% |
12,714
+298
| +2% | +$2.49K |
|
2043
SFL Corp
SFL
$1.06B
| $105K | ﹤0.01% |
11,266
-1,017
| -8% | -$9.48K |
|
|
TWKS
2044
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $105K | ﹤0.01% |
13,845
-4,012
| -22% | -$30.4K |
|
2045
Adaptive Biotechnologies
ADPT
$1.92B
| $104K | ﹤0.01% |
15,525
+3,883
| +33% | +$26K |
|
2046
Integral Ad Science
IAS
$1.4B
| $104K | ﹤0.01% |
5,795
+1,397
| +32% | +$25.1K |
|
2047
Weis Markets
WMK
$1.75B
| $104K | ﹤0.01% |
1,612
-126
| -7% | -$8.13K |
|
2048
First Busey Corp
BUSE
$2.19B
| $103K | ﹤0.01% |
5,127
-236
| -4% | -$4.74K |
|
2049
CNA Financial
CNA
$12.9B
| $103K | ﹤0.01% |
2,657
-62
| -2% | -$2.4K |
|
2050
Cogent Biosciences
COGT
$1.77B
| $103K | ﹤0.01% |
8,683
+1,977
| +29% | +$23.5K |
|